These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17765975)

  • 21. [Nitrates and coronary vascular endothelium dysfunction].
    Berdeaux A; Dubois-Randé JL; Hittinger L
    Ann Cardiol Angeiol (Paris); 1997; 46(7):391-8. PubMed ID: 9452772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous and exogenous nitrates.
    Anggård EE
    Acta Anaesthesiol Scand Suppl; 1992; 97():7-10. PubMed ID: 1557942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of nitric oxide in cardiovascular diseases.
    Naseem KM
    Mol Aspects Med; 2005; 26(1-2):33-65. PubMed ID: 15722114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide and cardiovascular system.
    Cengel A; Sahinarslan A
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):364-8. PubMed ID: 17162286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of nitric oxide in cardiovascular medicine: untapped potential utility.
    Pepine CJ
    Am J Med; 2009 May; 122(5 Suppl):S10-5. PubMed ID: 19393821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients.
    Willoughby SR; Rajendran S; Chan WP; Procter N; Leslie S; Liberts EA; Heresztyn T; Chirkov YY; Horowitz JD
    J Am Coll Cardiol; 2012 Sep; 60(10):887-94. PubMed ID: 22682555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-derived nitric oxide signaling and regulation.
    Gkaliagkousi E; Ritter J; Ferro A
    Circ Res; 2007 Sep; 101(7):654-62. PubMed ID: 17901370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide and nitrovasodilators: similarities, differences, and interactions.
    Kelly RA; Smith TW
    Am J Cardiol; 1996 May; 77(13):2C-7C. PubMed ID: 8638522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired interaction of platelets with endothelial progenitor cells in patients with cardiovascular risk factors.
    Dernbach E; Randriamboavonjy V; Fleming I; Zeiher AM; Dimmeler S; Urbich C
    Basic Res Cardiol; 2008 Nov; 103(6):572-81. PubMed ID: 18604625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond.
    Stepp DW
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):407-14. PubMed ID: 16700872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
    Gasparyan AY; Watson T; Lip GY
    J Am Coll Cardiol; 2008 May; 51(19):1829-43. PubMed ID: 18466797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure.
    Anderson RA; Ellis GR; Chirkov YY; Holmes AS; Payne N; Blackman DJ; Jackson SK; Lewis MJ; Horowitz JD; Frenneaux MP
    Eur J Heart Fail; 2004 Jan; 6(1):47-54. PubMed ID: 15012918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NO-donors in cardiology.
    Vapaatalo H
    Pol J Pharmacol; 1994; 46(6):531-40. PubMed ID: 7620515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide mechanisms of nebivolol.
    Maffei A; Lembo G
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ageing endothelium, cardiovascular risk and disease in man.
    Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S
    Exp Physiol; 2009 Mar; 94(3):317-21. PubMed ID: 18805864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vascular endothelium: target organ of cardiovascular pathologies].
    Berkenboom G
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):643-6. PubMed ID: 12555471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aging of platelet nitric oxide signaling: pathogenesis, clinical implications, and therapeutics.
    Procter NE; Chong CR; Sverdlov AL; Chan WP; Chirkov YY; Horowitz JD
    Semin Thromb Hemost; 2014 Sep; 40(6):660-8. PubMed ID: 25173501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular smooth muscle cell dysfunction in patients with migraine.
    Napoli R; Guardasole V; Zarra E; Matarazzo M; D'Anna C; Saccà F; Affuso F; Cittadini A; Carrieri PB; Saccà L
    Neurology; 2009 Jun; 72(24):2111-4. PubMed ID: 19528518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.